+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Role of PSA-related variables in improving positive ratio of biopsy of prostate cancer within serum PSA gray zone



Role of PSA-related variables in improving positive ratio of biopsy of prostate cancer within serum PSA gray zone



Urologia 81(3): 173-176



The aim of this study was to assess the validity of predictors of prostate biopsy outcome in order to improve their positive predictive value (PPV). The related variables of PSA such as free/total PSA ratio (F/T), complexed/total PSA ratio (C/T), density of PSA (PSAD) were studied to improve early diagnosis for early PCa within serum PSA gray zone. Samples of venous blood were collected early in the morning from 459 patients, aged 50 to 88 years (average 70.5 years old), whose serum T-PSA was between 4 to 10 ng/mL (153 cases of Pca, 306 cases of BPH). Serum T-PSA, F-PSA and C-PSA were determined by ELISA method; prostate volume was measured by transrectal ultrasound, then prostate biopsy was taken for all patients. Out of f 459 patients, 153 cases of Pca and 306 of BPH were diagnosed by prostate biopsy, whose mean values of T-PSA were 7.2 ± 1.25 ng/mL and 6.8 ± 0.96 ng/mL, respectively (P<0.05), of F/T were 0.117 ± 0.018 and 0.196 ± 0.021 (P<0.01), and of C/T they were 0.890 ± 0.023 and 0.754 ± 0.015 (P<0.01), of PSAD were 0.197 ± 0.023 and 0.106 ± 0.019 (P<0.01). The threshold of F/T>0.16 diagnosed 91 cases of cancer (59.5%), of C/T>0.84 88 cases (57.5%), of PSAD>0.15 94 cases (61.4%), and especially, of F/T>0.16 combined PSAD>0.15 80 cases whose sensitivity, specificity, accuracy, positive predictive values were 52.3%, 76.1%, 68.2%, 52.3%, respectively (P<0.05). There are some defects only in taking T-PSA as a biomarker for the diagnosis of PCa within serum PSA gray zone, and the threshold of F/T>0.16 combined PSAD>0.15 may be a new and significant indicator to provide a better basis for the diagnosis of early PCa.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 055599276

Download citation: RISBibTeXText

PMID: 24557815

DOI: 10.5301/urologia.5000051


Related references

Free/total ratio of prostate-specific antigen (PSA) for prostate cancer detection in patients with gray zone PSA level. Acta Urologica Japonica 43(12): 855-860, 1997

Free/total ratio of prostate-specific antigen (PSA) for prostate cancer detection in patients with gray zone PSA level. Hinyokika Kiyo. Acta Urologica Japonica 43(12): 855-860, 1997

Urinary/serum prostate-specific antigen ratio: comparison with free/total serum prostate-specific antigen ratio in improving prostate cancer detection. Urology 65(3): 533-537, 2005

Utility of prostate specific antigen (PSA) density in detecting prostate cancer in men showing gray zone serum PSA levels. Hinyokika Kiyo. Acta Urologica Japonica 43(1): 13-18, 1997

Free to total prostate-specific antigen (PSA) ratio improves the discrimination between prostate cancer and benign prostatic hyperplasia (BPH) in the diagnostic gray zone of 1.8 to 10 ng/mL total PSA. Urology 48(6 Suppl.): 67-70, 1996

Free to total prostate-specific antigen ratio improves the discrimination between prostate cancer and benign prostatic hyperplasia in the diagnostic gray zone of 18 to 10 ng/mL total PSA. Urology 48(6 Suppl. ): 67-70, 1996

The role of transrectal ultrasound-guided biopsy-based staging, preoperative serum prostate-specific antigen, and biopsy Gleason score in prediction of final pathologic diagnosis in prostate cancer. Urology 46(2): 205-212, 1995

Urinary-to-serum PSA ratio Comparison with free-to-total serum PSA in improving detection of prostate cancer. European Urology Suppl.s 3(2): 34, 2004

Role of transurethral resection of the prostate and biopsy of the peripheral zone in the same session after repeated negative biopsies in the diagnosis of prostate cancer. European Urology 49(5): 873-878, 2006

Usefulness of pre-biopsy multiparametric magnetic resonance imaging and clinical variables to reduce initial prostate biopsy in men with suspected clinically localized prostate cancer. Journal of Urology 190(2): 502-508, 2013

Is transition zone biopsy valuable in benign prostatic hyperplasia patients with serum prostate-specific antigen >10 ng/ml and prior negative peripheral zone biopsy?. Scandinavian Journal of Urology and Nephrology 39(1): 49-55, 2005

Transitional zone and anterior peripheral zone of the prostate. A correlation of small-volume cancer in the biopsy cores and high psa with positive anterior margins in radical prostatectomy specimens. Urologia Internationalis 66(4): 191-196, 2001

Role of prostate-specific antigen change ratio at initial biopsy as a novel decision-making marker for repeat prostate biopsy. Korean Journal of Urology 53(7): 467-471, 2012

In prostatism patients the ratio of human glandular kallikrein to free PSA improves the discrimination between prostate cancer and benign hyperplasia within the diagnostic gray zone of total PSA 4 to 10 ng/mL. Urology. 52(3): 360-365,., 1998

Examination of the 3 molecular forms of serum prostate specific antigen for distinguishing negative from positive biopsy: Relationship to transition zone volume. Journal of Urology 163(1): 119-126, 2000